Valogen Biosciences Limited
Private Limited Company · Kingsbridge
ActiveUnited KingdomIncorporated 2018Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2026-01-31
IXBRL · 120 source facts · 16 selected values
Validation findingsXBRL valid
Accounts to 2026-01-31
IXBRL · 120 source facts · 16 selected values
Validation findings
XBRL valid
- Reporting period
- 2025-02-01 to 2026-01-31
- Extraction status
- complete
- Numeric facts
- 68
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2604_11142238_20260131
- Source archive
- Accounts_Monthly_Data-April2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2025-01-31
IXBRL · 115 source facts · 16 selected values
Validation findingsXBRL valid
Accounts to 2025-01-31
IXBRL · 115 source facts · 16 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-02-01 to 2025-01-31
- Extraction status
- complete
- Numeric facts
- 63
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2504_11142238_20250131
- Source archive
- Accounts_Monthly_Data-April2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-01-31
IXBRL · 39 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2024-01-31
IXBRL · 39 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2023-02-01 to 2024-01-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 20
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2466_11142238_20240131
- Source archive
- Accounts_Monthly_Data-August2024.zip
Accounts to 2023-01-31
IXBRL · 37 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2023-01-31
IXBRL · 37 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2022-02-01 to 2023-01-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 18
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0025_11142238_20230131
- Source archive
- Accounts_Monthly_Data-September2023.zip
Accounts to 2022-01-31
IXBRL · 35 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2022-01-31
IXBRL · 35 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2021-02-01 to 2022-01-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0102_11142238_20220131
- Source archive
- Accounts_Monthly_Data-February2022.zip
Accounts to 2021-01-31
IXBRL · 35 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2021-01-31
IXBRL · 35 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2020-02-01 to 2021-01-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0088_11142238_20210131
- Source archive
- Accounts_Monthly_Data-March2021.zip
Accounts to 2020-01-31
IXBRL · 34 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2020-01-31
IXBRL · 34 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2019-02-01 to 2020-01-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0084_11142238_20200131
- Source archive
- Accounts_Monthly_Data-November2020.zip
Accounts to 2019-01-31
IXBRL · 25 source facts · 3 selected values
Not assessedlegacy record
Accounts to 2019-01-31
IXBRL · 25 source facts · 3 selected values
Not assessed
legacy record
- Reporting period
- 2018-01-10 to 2019-01-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 5
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0071_11142238_20190131
- Source archive
- Accounts_Monthly_Data-October2019.zip
Registered details
11142238- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2018-01-10
- Jurisdiction
- —
- Registered office
- UPTON BARTON, SOUTH MILTON, KINGSBRIDGE, SOUTH DEVON, TQ7 3JF, UNITED KINGDOM
Classification
1 SIC codes23101
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
2 SH01-derived rounds2025-07-05
£153,919 raised
£2,625,735 estimated post-money
2023-10-27
£99,936 raised
£663,591 estimated post-money
Research and innovation
2 matched grantsDevelopment of a novel circular economy plant protein derivative as a readily digestible dietary ingredient to support healthy ageingLeadInnovate UK · Collaborative R&D · 2023-09-01 – 2025-01-31 · with 1 other participant£122,791awarded
Development of a novel circular economy plant protein derivative as a readily digestible dietary ingredient to support healthy ageingLead
Innovate UK · Collaborative R&D · 2023-09-01 – 2025-01-31 · with 1 other participant
£122,791
awarded
University of Plymouth£164,091
Valogen Biosciences Limitedlead£122,791
High-Value Biorenewable Peptides from Proteinaceous BiomassLeadInnovate UK · Collaborative R&D · 2022-02-01 – 2024-01-31 · with 2 other participants£172,188awarded
High-Value Biorenewable Peptides from Proteinaceous BiomassLead
Innovate UK · Collaborative R&D · 2022-02-01 – 2024-01-31 · with 2 other participants
£172,188
awarded
Valogen Biosciences Limitedlead£172,188